Transforming Healthcare Through Patient-Centric, Point-of-Need Ophthalmic Assessments

Revolutionizing Access to Eye Care Across Clinical Research and Beyond



20/20 Onsite is reshaping healthcare delivery by bridging critical clinical research and community health gaps through innovative, patient-centric, point-of-need ophthalmic assessments. With 70% of potential trial participants living more than two hours from a study center, access remains a major barrier. 20/20 Onsite’s point-of-need vision clinics bring care directly to patients—at home, work, or in their communities—cutting travel distances from an average of 67 miles to just 12 miles, improving access and outcomes.



This model’s impact extends well beyond convenience, driving significant advancements:

Recruitment and Retention: With 30% of clinical trial patients dropping out, 20/20 Onsite eliminates logistical burdens, increasing enrollment and retention rates. Trials supported by MVCs have achieved Net Promoter Scores (NPS) above 90, reflecting unmatched patient satisfaction.

Data Quality: Certified staff and state-of-the-art equipment ensure data accuracy rates of 98%, a critical factor for trial reliability.



20/20 Onsite doesn’t just serve clinical research. Its programs extend across underserved communities to deliver equitable access to care:

Schools Program: In collaboration with Boston Public Schools, 20/20 Onsite provided students free eye exams and glasses to over 55 schools and 155 community events, addressing a critical gap in pediatric eye care.

American Diabetes Association® Collaboration: By offering free eye screenings at events like the Step Out Walk to Stop Diabetes, 20/20 Onsite raises awareness and delivers vital care to communities affected by diabetes.



With a flexible hybrid model, 20/20 Onsite tailors solutions for trial sponsors and underserved populations alike:

Mobile Vision Clinics: Fully equipped units perform advanced ophthalmic assessments anywhere they’re needed.

Regulatory Support: Expertise in integrating ophthalmic endpoints ensures compliance and trial success.



These efforts reduce costly delays—ranging from $600,000 to $8 million per day—and expand access to diverse populations, offering greater equity in healthcare.



With over 85,000 patients served and 1,700 clinical trial participants assessed, 20/20 Onsite is setting a new benchmark in healthcare. By reducing access barriers, increasing retention, and improving data quality, the company ensures better outcomes for patients, sponsors, and communities alike.